MARKET

EVFM

EVFM

Evofem Bioscienc
OTCMQB
0.070
0.000
0.00%
Opening 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.070
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
196.25
52 WEEK LOW
0.013
MARKET CAP
751.11K
P/E (TTM)
-0.0035
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at EVFM last week (1127-1201)?
Weekly Report · 1d ago
Weekly Report: what happened at EVFM last week (1120-1124)?
Weekly Report · 11/27 10:58
Weekly Report: what happened at EVFM last week (1113-1117)?
Weekly Report · 11/20 10:56
Evofem Biosciences GAAP EPS of $0.10, revenue of $5.11M
Evofem biosciences reports q3 gaap eps of $0.10, revenue of $5.11m (-19.8% y/y) evofem says no phexxi generic until 2033 after company amends anda.
Seeking Alpha · 11/14 11:58
Weekly Report: what happened at EVFM last week (1106-1110)?
Weekly Report · 11/13 10:50
Weekly Report: what happened at EVFM last week (1030-1103)?
Weekly Report · 11/06 10:54
Weekly Report: what happened at EVFM last week (1023-1027)?
Weekly Report · 10/30 11:08
Evofem Biosciences expects to see third consecutive quarter of growth
Seeking Alpha · 10/24 13:14
More
About EVFM
Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company. It is engaged in developing and commercializing products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). Its product, Phexxi vaginal gel, is a hormone-free, woman-controlled, on-demand prescription contraceptive gel for women. Its lead clinical program is evaluating Phexxi (using the investigational name EVO100) for the prevention of chlamydia and gonorrhea in women. EVO200 vaginal gel (EVO200), its investigational candidate for the reduction of recurrent bacterial vaginosis (BV), uses the same vaginal potential of hydrogen (pH) modulator platform as Phexxi. It also focuses on developing Multipurpose Prevention Technology (MPT) vaginal gel for indications, including the prevention of human immunodeficiency virus (HIV) in women through Orion Biotechnology Canada Ltd.

Webull offers Evofem Biosciences Inc stock information, including OTCMQB: EVFM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EVFM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EVFM stock methods without spending real money on the virtual paper trading platform.